{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T01:13:58Z","timestamp":1768785238278,"version":"3.49.0"},"reference-count":42,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The potential use of\n            <jats:italic>Yersinia pestis<\/jats:italic>\n            as a bioterror agent is a great concern. Development of a stable powder vaccine against\n            <jats:italic>Y. pestis<\/jats:italic>\n            and administration of the vaccine by minimally invasive methods could provide an alternative to the traditional liquid formulation and intramuscular injection. We evaluated a spray-freeze-dried powder vaccine containing a recombinant F1-V fusion protein of\n            <jats:italic>Y. pestis<\/jats:italic>\n            for vaccination against plaque in a mouse model. Mice were immunized with reconstituted spray-freeze-dried F1-V powder via intramuscular injection, microneedle-based intradermal delivery, or noninvasive intranasal administration. By intramuscular injection, the reconstituted powder induced serum antibody responses and provided protection against lethal subcutaneous challenge with 1,000 50% lethal doses of\n            <jats:italic>Y. pestis<\/jats:italic>\n            at levels equivalent to those elicited by unprocessed liquid formulations (70 to 90% protection). The feasibility of intradermal and intranasal delivery of reconstituted powder F1-V vaccine was also demonstrated. Overall, microneedle-based intradermal delivery was shown to be similar in efficacy to intramuscular injection, while intranasal administration required an extra dose of vaccine to achieve similar protection. In addition, the results suggest that seroconversion against F1 may be a better predictor of protection against\n            <jats:italic>Y. pestis<\/jats:italic>\n            challenge than seroconversion against either F1-V or V. In summary, we demonstrate the preclinical feasibility of using a reconstituted powder F1-V formulation and microneedle-based intradermal delivery to provide protective immunity against plague in a mouse model. Intranasal delivery, while feasible, was less effective than injection in this study. The potential use of these alternative delivery methods and a powder vaccine formulation may result in substantial health and economic benefits.\n          <\/jats:p>","DOI":"10.1128\/cvi.00447-08","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T02:36:28Z","timestamp":1236220588000},"page":"719-725","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":42,"title":["Protective Immunity in Mice Achieved with Dry Powder Formulation and Alternative Delivery of Plague F1-V Vaccine"],"prefix":"10.1128","volume":"16","author":[{"given":"Joanne","family":"Huang","sequence":"first","affiliation":[{"name":"BD Technologies, 21 Davis Drive, Research Triangle Park, North Carolina 27709"},{"name":"U.S. Army Medical Research Institute for Infectious Diseases, Frederick, Maryland 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajit J.","family":"D'Souza","sequence":"additional","affiliation":[{"name":"BD Technologies, 21 Davis Drive, Research Triangle Park, North Carolina 27709"},{"name":"U.S. Army Medical Research Institute for Infectious Diseases, Frederick, Maryland 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason B.","family":"Alarcon","sequence":"additional","affiliation":[{"name":"BD Technologies, 21 Davis Drive, Research Triangle Park, North Carolina 27709"},{"name":"U.S. Army Medical Research Institute for Infectious Diseases, Frederick, Maryland 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Mikszta","sequence":"additional","affiliation":[{"name":"BD Technologies, 21 Davis Drive, Research Triangle Park, North Carolina 27709"},{"name":"U.S. Army Medical Research Institute for Infectious Diseases, Frederick, Maryland 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandi M.","family":"Ford","sequence":"additional","affiliation":[{"name":"BD Technologies, 21 Davis Drive, Research Triangle Park, North Carolina 27709"},{"name":"U.S. Army Medical Research Institute for Infectious Diseases, Frederick, Maryland 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Ferriter","sequence":"additional","affiliation":[{"name":"BD Technologies, 21 Davis Drive, Research Triangle Park, North Carolina 27709"},{"name":"U.S. Army Medical Research Institute for Infectious Diseases, Frederick, Maryland 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Evans","sequence":"additional","affiliation":[{"name":"BD Technologies, 21 Davis Drive, Research Triangle Park, North Carolina 27709"},{"name":"U.S. Army Medical Research Institute for Infectious Diseases, Frederick, Maryland 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Stewart","sequence":"additional","affiliation":[{"name":"BD Technologies, 21 Davis Drive, Research Triangle Park, North Carolina 27709"},{"name":"U.S. Army Medical Research Institute for Infectious Diseases, Frederick, Maryland 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Amemiya","sequence":"additional","affiliation":[{"name":"BD Technologies, 21 Davis Drive, Research Triangle Park, North Carolina 27709"},{"name":"U.S. Army Medical Research Institute for Infectious Diseases, Frederick, Maryland 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Ulrich","sequence":"additional","affiliation":[{"name":"BD Technologies, 21 Davis Drive, Research Triangle Park, North Carolina 27709"},{"name":"U.S. Army Medical Research Institute for Infectious Diseases, Frederick, Maryland 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent J.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"BD Technologies, 21 Davis Drive, Research Triangle Park, North Carolina 27709"},{"name":"U.S. Army Medical Research Institute for Infectious Diseases, Frederick, Maryland 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00387-06"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1164\/ajrccm.161.4.16141","volume":"161","year":"2000","unstructured":"American Thoracic Society and Centers for Disease Control and Prevention. 2000. Diagnostic standards and classification of tuberculosis in adults and children. Am. J. Respir. Crit. Care Med.161:1376-1395.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.11.4580-4585.1996"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1997.56.471","volume":"56","year":"1997","unstructured":"Anderson, G. W., Jr., P. L. Worsham, C. R. Bolt, G. P. Andrews, S. L. Welkos, A. M. Friedlander, and J. P. Burans. 1997. Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis. Am. J. Trop. Med. Hyg.56:471-473.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0264-410X(00)00228-0","volume":"19","year":"2000","unstructured":"Anderson, J., E. Fishbourne, A. Corteyn, and A. I. Donaldson. 2000. Protection of cattle against rinderpest by intranasal immunisation with a dry powder tissue culture vaccine. Vaccine19:840-843.","journal-title":"Vaccine"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.6.2180-2187.1996"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa043555","volume":"351","year":"2004","unstructured":"Belshe, R. B., F. K. Newman, J. Cannon, C. Duane, J. Treanor, C. Van Hoecke, B. J. Howe, and G. Dubin. 2004. Serum antibody responses after intradermal vaccination against influenza. N. Engl. J. Med.351:2286-2294.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0264-410X(92)90416-H","volume":"10","year":"1992","unstructured":"Bryan, J. P., M. H. Sjogren, P. Macarthy, E. Cox, L. J. Legters, and P. L. Perine. 1992. Persistence of antibody to hepatitis B surface antigen after low-dose, intradermal hepatitis B immunization and response to a booster dose. Vaccine10:33-38.","journal-title":"Vaccine"},{"key":"e_1_3_2_10_2","first-page":"59","volume":"37","year":"1963","unstructured":"Burrows, T. W. 1963. Virulence of Pasteurella pestis and immunity to plague. Ergeb. Mikrobiol. Immunitatsforsch. Exp. Ther.37:59-113.","journal-title":"Ergeb. Mikrobiol. Immunitatsforsch. Exp. Ther."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.1967.03130170165036","volume":"202","year":"1967","unstructured":"Cohen, R. J., and J. L. Stockard. 1967. Pneumonic plague in an untreated plague-vaccinated individual. JAMA202:365-366.","journal-title":"JAMA"},{"key":"e_1_3_2_12_2","first-page":"1","volume":"49","year":"2000","unstructured":"Cohn, D., and R. J. O'Brien. 2000. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb. Mortal. Wkly. Rep.49:1-54.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.vaccine.2006.10.019","volume":"25","year":"2007","unstructured":"de Swart, R. L., C. LiCalsi, A. V. Quirk, G. van Amerongen, V. Nodelman, R. Alcock, S. Yuksel, G. H. Ward, J. G. Hardy, H. Vos, C. L. Witham, C. I. Grainger, T. Kuiken, B. J. Greenspan, T. G. Gard, and A. D. Osterhaus. 2007. Measles vaccination of macaques by dry powder inhalation. Vaccine25:1183-1190.","journal-title":"Vaccine"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199709043371004","volume":"337","year":"1997","unstructured":"Galimand, M., A. Guiyoule, G. Gerbaud, B. Rasoamanana, S. Chanteau, E. Carniel, and P. Courvalin. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med.337:677-680.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","volume":"16","year":"1998","unstructured":"Heath, D. G., G. W. Anderson, Jr., J. M. Mauro, S. L. Welkos, G. P. Andrews, J. Adamovicz, and A. M. Friedlander. 1998. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine16:1131-1137.","journal-title":"Vaccine"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.4.2234-2238.2003"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.11.4476-4482.1997"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.vaccine.2004.06.049","volume":"23","year":"2004","unstructured":"Huang, J., R. J. Garmise, T. M. Crowder, K. Mar, C. R. Hwang, A. J. Hickey, J. A. Mikszta, and V. J. Sullivan. 2004. A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats. Vaccine23:794-801.","journal-title":"Vaccine"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4161\/hv.3.3.4011","volume":"3","year":"2007","unstructured":"Huang, J., J. A. Mikszta, M. S. Ferriter, G. Jiang, N. G. Harvey, B. Dyas, C. J. Roy, R. G. Ulrich, and V. J. Sullivan. 2007. Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge. Hum. Vaccin.3:90-93.","journal-title":"Hum. Vaccin."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00171-5","volume":"51","year":"2001","unstructured":"Illum, L., I. Jabbal-Gill, M. Hinchcliffe, A. N. Fisher, and S. S. Davis. 2001. Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev.51:81-96.","journal-title":"Adv. Drug Deliv. Rev."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","volume":"283","year":"2000","unstructured":"Inglesby, T. V., D. T. Dennis, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, A. M. Friedlander, J. Hauer, J. F. Koerner, M. Layton, J. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, M. Schoch-Spana, K. Tonat, et al. 2000. Plague as a biological weapon: medical and public health management. JAMA283:2281-2290.","journal-title":"JAMA"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jps.20484","volume":"95","year":"2006","unstructured":"Jiang, G., S. B. Joshi, L. J. Peek, D. T. Brandau, J. Huang, M. S. Ferriter, W. D. Woodley, B. M. Ford, K. D. Mar, J. A. Mikszta, C. R. Hwang, R. Ulrich, N. G. Harvey, C. R. Middaugh, and V. J. Sullivan. 2006. Anthrax vaccine powder formulations for nasal mucosal delivery. J. Pharm. Sci.95:80-96.","journal-title":"J. Pharm. Sci."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1016\/S0264-410X(03)00379-7","volume":"21","year":"2003","unstructured":"Jones, S. M., K. F. Griffin, I. Hodgson, and E. D. Williamson. 2003. Protective efficacy of a fully recombinant plague vaccine in the guinea pig. Vaccine21:3912-3918.","journal-title":"Vaccine"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.vaccine.2005.09.052","volume":"24","year":"2006","unstructured":"Jones, T., J. J. Adamovicz, S. L. Cyr, C. R. Bolt, N. Bellerose, L. M. Pitt, G. H. Lowell, and D. S. Burt. 2006. Intranasal Protollin\/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection. Vaccine24:1625-1632.","journal-title":"Vaccine"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa043540","volume":"351","year":"2004","unstructured":"Kenney, R. T., S. A. Frech, L. R. Muenz, C. P. Villar, and G. M. Glenn. 2004. Dose sparing with intradermal injection of influenza vaccine. N. Engl. J. Med.351:2295-2301.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.1016\/j.vaccine.2007.10.020","volume":"25","year":"2007","unstructured":"Laurent, P. E., S. Bonnet, P. Alchas, P. Regolini, J. A. Mikszta, R. Pettis, and N. G. Harvey. 2007. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine25:8833-8842.","journal-title":"Vaccine"},{"key":"e_1_3_2_27_2","first-page":"653","volume":"42","year":"1970","unstructured":"Meyer, K. F. 1970. Effectiveness of live or killed plague vaccines in man. Bull. W. H. O.42:653-666.","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01210-06"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1086\/426865","volume":"191","year":"2005","unstructured":"Mikszta, J. A., V. J. Sullivan, C. Dean, A. M. Waterston, J. B. Alarcon, J. P. Dekker III, J. M. Brittingham, J. Huang, C. R. Hwang, M. Ferriter, G. Jiang, K. Mar, K. U. Saikh, B. G. Stiles, C. J. Roy, R. G. Ulrich, and N. G. Harvey. 2005. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J. Infect. Dis.191:278-288.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/092986708783503249","volume":"15","year":"2008","unstructured":"Moyle, P. M., and I. Toth. 2008. Self-adjuvanting lipopeptide vaccines. Curr. Med. Chem.15:506-516.","journal-title":"Curr. Med. Chem."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1118476","volume":"310","year":"2005","unstructured":"Mueller, C. A., P. Broz, S. A. Muller, P. Ringler, F. Erne-Brand, I. Sorg, M. Kuhn, A. Engel, and G. R. Cornelis. 2005. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science310:674-676.","journal-title":"Science"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","volume":"6","year":"2006","unstructured":"Neutra, M. R., and P. A. Kozlowski. 2006. Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol.6:148-158.","journal-title":"Nat. Rev. Immunol."},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/bp050098r","volume":"21","year":"2005","unstructured":"Powell, B. S., G. P. Andrews, J. T. Enama, S. Jendrek, C. Bolt, P. Worsham, J. K. Pullen, W. Ribot, H. Hines, L. Smith, D. G. Heath, and J. J. Adamovicz. 2005. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol. Prog.21:1490-1510.","journal-title":"Biotechnol. Prog."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","volume":"13","year":"1995","unstructured":"Russell, P., S. M. Eley, S. E. Hibbs, R. J. Manchee, A. J. Stagg, and R. W. Titball. 1995. A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine13:1551-1556.","journal-title":"Vaccine"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1517\/17425247.3.1.87","volume":"3","year":"2006","unstructured":"Sullivan, V. J., J. A. Mikszta, P. Laurent, J. Huang, and B. Ford. 2006. Noninvasive delivery technologies: respiratory delivery of vaccines. Exp. Opin. Drug Deliv.3:87-95.","journal-title":"Exp. Opin. Drug Deliv."},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1016\/j.vaccine.2007.09.030","volume":"25","year":"2007","unstructured":"Uddowla, S., L. C. Freytag, and J. D. Clements. 2007. Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens. Vaccine25:7984-7993.","journal-title":"Vaccine"},{"key":"e_1_3_2_37_2","unstructured":"USAMRIID's Medical Management of Biological Casualties Handbook 2005"},{"key":"e_1_3_2_38_2","first-page":"301","year":"1983","unstructured":"Warrell, M. J., D. A. Warrell, P. Suntharasamai, C. Viravan, A. Sinhaseni, D. Udomsakdi, R. Phanfung, C. Xueref, J. C. Vincent-Falquet, K. G. Nicholson, D. Bunnag, and T. Harinasuta. 1983. An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis. Lancetii:301-304.","journal-title":"Lancet"},{"key":"e_1_3_2_39_2","first-page":"299","volume":"13","year":"1995","unstructured":"Welkos, S. L., K. M. Davis, L. M. Pitt, P. L. Worsham, and A. M. Freidlander. 1995. Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis. Contrib. Microbiol. Immunol.13:299-305.","journal-title":"Contrib. Microbiol. Immunol."},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/mpat.1997.0154","volume":"23","year":"1997","unstructured":"Welkos, S. L., A. M. Friedlander, and K. J. Davis. 1997. Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain C092. Microb. Pathog.23:211-223.","journal-title":"Microb. Pathog."},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1365-2672.2001.01497.x","volume":"91","year":"2001","unstructured":"Williamson, E. D. 2001. Plague vaccine research and development. J. Appl. Microbiol.91:606-608.","journal-title":"J. Appl. Microbiol."},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","volume":"12","year":"1995","unstructured":"Williamson, E. D., S. M. Eley, K. F. Griffin, M. Green, P. Russell, S. E. Leary, P. C. Oyston, T. Easterbrook, K. M. Reddin, A. Robinson, et al. 1995. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol. Med. Microbiol.12:223-230.","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","volume":"15","year":"1997","unstructured":"Williamson, E. D., S. M. Eley, A. J. Stagg, M. Green, P. Russell, and R. W. Titball. 1997. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine15:1079-1084.","journal-title":"Vaccine"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00447-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00447-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T15:55:07Z","timestamp":1627574107000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00447-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1128\/CVI.00447-08"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00447-08","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"2008-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-02-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}